Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

  1. Öcal, O.
  2. Rössler, D.
  3. Gasbarrini, A.
  4. Berg, T.
  5. Klümpen, H.-J.
  6. Bargellini, I.
  7. Peynircioglu, B.
  8. van Delden, O.
  9. Schulz, C.
  10. Schütte, K.
  11. Iezzi, R.
  12. Pech, M.
  13. Malfertheiner, P.
  14. Sangro, B.
  15. Ricke, J.
  16. Seidensticker, M.
Revue:
Journal of Cancer Research and Clinical Oncology

ISSN: 1432-1335,  0171-5216

Année de publication: 2022

Volumen: 148

Número: 9

Pages: 2487-2496

Type: Article

DOI: 10.1007/S00432-021-03803-3 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus